FDA Provides 2020 Rheumatology Drug Update
Emergency Use Approved for Baricitinib with Remdesivir Combination Therapy for SARS-CoV-2
FDA Warning: Avoid Use of NSAIDs after Week 20 of Pregnancy
FDA Approves Golimumab for Patients with pJIA & Psoriatic Arthritis
FDA Approves Tofacitinib for Young Patients with Active Polyarticular JIA
FDA Updates Boxed Warning of Benzodiazepines, Adding Risks for Abuse & Addiction
FDA Receives Upadacitinib Application for Ankylosing Spondylitis & Approves Tramadol Hydrochloride Oral Solution
U.S. & E.U. Differ on Filgotinib for RA
ACR Leaders Discuss Hydroxychloroquine Issues with FDA Commissioner
- 1
- 2
- 3
- …
- 10
- Next Page »